Skip to main content
. 2015 Mar 20;2015(3):CD003988. doi: 10.1002/14651858.CD003988.pub2

8.3. Analysis.

Comparison 8 COC (norethinodrone 1 mg + EE 35 μg) versus POP (norethinodrone 350 μg), Outcome 3 Breastfeeding discontinuation by 6 months.

Breastfeeding discontinuation by 6 months
Study Variable Reported
 hazard ratio Reported
 95% CI Reported
 P value
Espey 2012 Group: COC versus POP 1.42 0.76 to 2.65 .270
Espey 2012 Supplementing: yes versus no 2.81 1.09 to 7.23 .033
Espey 2012 Milk concerns: yes versus no 2.07 1.37 to 5.91 .005